Dear Friends and Colleagues,
In the best interest of our VCS members, non-member attendees, and our speakers, the VCS conference committee decided earlier this year to postpone the Mid-Year Conference scheduled for April of 2021. We are now happy to let you know that the conference has been rescheduled to April 9-12, 2022 in Puerto Vallarta, Mexico. With the pandemic still playing havoc with nations across the world, we know that postponing the conference this year was the best one possible. With a vaccine being available in many locations around the world, with hopes of even greater distribution as the year goes on, we are hopeful that we will be able to meet in person again next spring.
We have begun work to augment our originally scheduled agenda with the latest and greatest evidence and trajectories in the fields of cancer immunotherapy and targeted therapy and expect an outstanding opportunity for an in person meeting in Mexico next year. Stay tuned for a list of presenters and topics and mark your calendar so that you can join us. Limited rooms and capacity will be available for this conference with registration and the room block opening in November.
Until then, stay well!
Dr. Chand Khanna
DVM, PhD, DACVIM (Onc), DACVP (Hon)
Conference Chairman
